Associated Papers
Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer.
Thiyagarajan T et al.
Proceedings of the National Academy of Sciences of the United States of America, 2023
Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations.
Chen S et al.
Biochemistry, 2002
Select a paper to view details